BioInformant.com is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by the Wall Street Journal, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

Page

Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends

By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2019 | Page 195

CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer. ....

USD 3795 View Report

Complete 2017-18 Global Cord Blood Banking Industry Report

By BioInformant Worldwide, L.L.C. | Healthcare | Oct 2017 | Page 265

DescriptionOver the past five years, the global cord blood banking industry has substantially matured and consolidated. This has created both serious threats and novel opportunities for the industry. Serious threats....

USD 4995 View Report

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution

By BioInformant Worldwide, L.L.C. | Pharmaceuticals and Healthcare | Jul 2017 | Page 123

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution    Traditionally, one of the major issues with commercializing cell therapy products has been manufacturing....

USD 2495 View Report

Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives

By BioInformant Worldwide, L.L.C. | Pharmaceuticals and Healthcare | Jul 2017 | Page 166

Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives Stem cell research has been in process for over five decades. Stem cells have a....

USD 1795 View Report